I-High Purity Ready Stock 61825-94-3 i-Oxaliplatin yezidakamizwa zePlatinum Anticancer
Umkhiqizoigama | I-Oxaliplatin |
Omqondofana | I-trans-L-Diaminocyclohexane oxalatoplatinum |
Inombolo ye-CAS. | 61825-94-3 |
Ukubukeka | Impushana ecwebezelayo emhlophe ukuya emhlophe |
I-Molecular Formula | C8H12N2O4Pt |
Isisindo samangqamuzana | 395.27 |
Ukusetshenziswa | Ibanga Lezemithi noma inhloso yocwaningo |
Ukupakisha | Njengesicelo sakho |
Isitoreji | Londoloza ezitsheni eziqinile, ezimelana nokukhanya endaweni epholile |
I-OxaliplatinI-Cas:61825-94-3 | ||
Izinto | Okujwayelekile | Imiphumela |
Ukubukeka | Impushana emhlophe emhlophe noma ecishe ibe mhlophe | I-crystalline powder emhlophe |
Ukuncibilika | Incibilika kancane emanzini, incibilika kancane ku-methanol, cishe ayincibiliki ku-ethanol engena-hydrous | Iyahambisana |
Ukuhlonza | I-spectrum yesampula kufanele ihambisane ne-spectrum yezinga lereferensi | A.IyahambisanaB.Iyavumelana |
Ukubonakala kwesixazululo | Isixazululo sicacile futhi asinambala | Iyahambisana |
I-Acidity | Kudingeka ngaphezu kuka-0.6ml ka-0.01M NaOH ukuze uguqule umbala wenkomba ube ophinki | Iyahambisana |
I-optical ethile ukuzungeza | +74.5°~+78.0° | +75.9° |
Izinto ezihlobene | UkungcolaA:NMT0.10%UkungcolaB: NMT0.10% I-ImpurityC: NMT0.10% Noma yikuphi okunye ukungcola:NMT0.10% Isamba sokunye ukungcola: NMT0.10% (faka ukungcola C) Isamba sokungcola: NMT0.30% | UkungcolaA: 0.04% UkungcolaB:0.01%I-ImpurityC: 0.001% Noma yikuphi okunye ukungcola: 0.002% Isamba sobunye ukungcola: 0.01% Isamba sokungcola: 0.03% |
Ukungcola D | I-NMT0.10% | ND |
Isiliva | I-NMT5.0ppm | 0.08ppm |
Ukulahlekelwa ekomisweni | I-NMT0.5% | 0.09% |
Isivivinyo | 98.0~102.0% (into eyomisiwe) | 99.7% |
Isiphetho:Imiphumela ibonisa ukuthi umkhiqizo uhambisana ne-EP9.0 |
Ulwazi Lwenkampani
√ Isipiliyoni esigcwele se-Management layer kubalandeli befektri nabanekhono; √ Ikhwalithi ihlale iwukucatshangelwa kwethu okuphezulu, uhlelo oluqinile lwe-QC; √ Ithimba leminyaka engu-11 elinesipiliyoni sokuthumela ngaphandle; √ Ilebhu ye-R&D ezimele; √ Izinkundla zokucobelelana ngolwazi ezimbili ze-GMP zesikhathi eside ezisayiniwe; √ Izinsiza ezicebile zamafekthri amaningi angasebenzi wephrojekthi eyenziwe ngokwezifiso; √ Ithimba elisebenzayo elisebenza kahle elinendlela engaguquki.Bhala umyalezo wakho lapha futhi usithumelele wona